OP
GWPH

Omni Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Omni Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$87.4M Buy
+403,061
New +$75.8M 4.31% 6

Other funds holding GWPH

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Omni Partners's GWPH Position: Q1 2021 in Review

Omni Partners opened a new position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021: 403,061 shares worth $87.4M. The stake represents 4.31% of the portfolio and ranks #6 among its holdings.

297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Omni Partners held 403,061 shares of GW Pharmaceuticals Plc American Depositary Shares worth $87.4M as of Q1 2021.
  • GW Pharmaceuticals Plc American Depositary Shares was a new Omni Partners position in Q1 2021.
  • GW Pharmaceuticals Plc American Depositary Shares made up 4.31% of Omni Partners's portfolio in Q1 2021, its #6 holding.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Omni Partners's 13F filing for Q1 2021, filed 17 May 2021.